These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 29565447)

  • 1. CAFs enhance paclitaxel resistance by inducing EMT through the IL‑6/JAK2/STAT3 pathway.
    Wang L; Zhang F; Cui JY; Chen L; Chen YT; Liu BW
    Oncol Rep; 2018 May; 39(5):2081-2090. PubMed ID: 29565447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway.
    Wang Y; Jing Y; Ding L; Zhang X; Song Y; Chen S; Zhao X; Huang X; Pu Y; Wang Z; Ni Y; Hu Q
    J Exp Clin Cancer Res; 2019 Jun; 38(1):274. PubMed ID: 31234944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of JAK2 Reverses Paclitaxel Resistance in Human Ovarian Cancer Cells.
    Xu Y; Zhang J; Wu J; Zhong S; Li H
    Int J Gynecol Cancer; 2015 Nov; 25(9):1557-64. PubMed ID: 26360705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway.
    Wu X; Tao P; Zhou Q; Li J; Yu Z; Wang X; Li J; Li C; Yan M; Zhu Z; Liu B; Su L
    Oncotarget; 2017 Mar; 8(13):20741-20750. PubMed ID: 28186964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling.
    Goulet CR; Champagne A; Bernard G; Vandal D; Chabaud S; Pouliot F; Bolduc S
    BMC Cancer; 2019 Feb; 19(1):137. PubMed ID: 30744595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular Vesicles from Carcinoma-associated Fibroblasts Promote EMT of Salivary Adenoid Cystic Carcinoma Via IL-6.
    Al-Raimi HAI; Kong J; Ran Y; Zhu L; Li J; Liu X; Yang X; Qi D; Liu T
    Arch Med Res; 2023 Jan; 54(1):27-36. PubMed ID: 36543625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer.
    Kim MS; Lee WS; Jeong J; Kim SJ; Jin W
    Oncotarget; 2015 Nov; 6(37):40158-71. PubMed ID: 26515594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer.
    Duan Z; Foster R; Bell DA; Mahoney J; Wolak K; Vaidya A; Hampel C; Lee H; Seiden MV
    Clin Cancer Res; 2006 Sep; 12(17):5055-63. PubMed ID: 16951221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.
    Soon PS; Kim E; Pon CK; Gill AJ; Moore K; Spillane AJ; Benn DE; Baxter RC
    Endocr Relat Cancer; 2013 Feb; 20(1):1-12. PubMed ID: 23111755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non-Small Cell Lung Cancer.
    Shien K; Papadimitrakopoulou VA; Ruder D; Behrens C; Shen L; Kalhor N; Song J; Lee JJ; Wang J; Tang X; Herbst RS; Toyooka S; Girard L; Minna JD; Kurie JM; Wistuba II; Izzo JG
    Mol Cancer Ther; 2017 Oct; 16(10):2234-2245. PubMed ID: 28729401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrphostin B42 attenuates trichostatin A-mediated resistance in pancreatic cancer cells by antagonizing IL-6/JAK2/STAT3 signaling.
    Zhang X; Lu H; Hong W; Liu L; Wang S; Zhou M; Chen B; Bai Y
    Oncol Rep; 2018 Apr; 39(4):1892-1900. PubMed ID: 29393444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer.
    Liu S; Sun J; Cai B; Xi X; Yang L; Zhang Z; Feng Y; Sun Y
    Tumour Biol; 2016 Jul; 37(7):9671-80. PubMed ID: 26801672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden.
    Abubaker K; Luwor RB; Zhu H; McNally O; Quinn MA; Burns CJ; Thompson EW; Findlay JK; Ahmed N
    BMC Cancer; 2014 May; 14():317. PubMed ID: 24886434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of GP130/STAT3 and EMT by combined bazedoxifene and paclitaxel treatment in ovarian cancer.
    Park SA; Kim LK; Park HM; Kim HJ; Heo TH
    Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 35029286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose Stromal Cells from Visceral and Subcutaneous Fat Facilitate Migration of Ovarian Cancer Cells via IL-6/JAK2/STAT3 Pathway.
    Kim B; Kim HS; Kim S; Haegeman G; Tsang BK; Dhanasekaran DN; Song YS
    Cancer Res Treat; 2017 Apr; 49(2):338-349. PubMed ID: 27456942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
    Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [SP13786 Inhibits the Migration and Invasion of Lung Adenocarcinoma Cell A549 
by Supressing Stat3-EMT via CAFs Exosomes].
    Wang S; Cui J; Zhang K; Gu J; Zheng Y; Zhang B; Shi L
    Zhongguo Fei Ai Za Zhi; 2021 Jun; 24(6):384-393. PubMed ID: 34024061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth.
    McLean K; Tan L; Bolland DE; Coffman LG; Peterson LF; Talpaz M; Neamati N; Buckanovich RJ
    Oncogene; 2019 Feb; 38(9):1576-1584. PubMed ID: 30305729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for cancer-associated fibroblasts in inducing the epithelial-to-mesenchymal transition in human tongue squamous cell carcinoma.
    Zhou B; Chen WL; Wang YY; Lin ZY; Zhang DM; Fan S; Li JS
    J Oral Pathol Med; 2014 Sep; 43(8):585-92. PubMed ID: 24645915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-associated fibroblasts in a human HEp-2 established laryngeal xenografted tumor are not derived from cancer cells through epithelial-mesenchymal transition, phenotypically activated but karyotypically normal.
    Wang M; Wu CP; Pan JY; Zheng WW; Cao XJ; Fan GK
    PLoS One; 2015; 10(2):e0117405. PubMed ID: 25658113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.